Why has NICE said this?
NICE looks at how well treatments work in relation to how much they cost compared with other treatments available on the NHS.
NICE applies special considerations to treatments that can extend the lives of people who are nearing the end of their life. Ipilimumab was recommended because it works as well or better than other treatments available on the NHS. Although it costs more than other treatments, this was justified by the benefits it provided when the special considerations were applied.